Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA214030
Max Phase: Preclinical
Molecular Formula: C14H17N3O3
Molecular Weight: 275.31
Molecule Type: Small molecule
Associated Items:
ID: ALA214030
Max Phase: Preclinical
Molecular Formula: C14H17N3O3
Molecular Weight: 275.31
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C1N[C@@H](Cc2ccccc2)C(=O)N2C[C@H](O)C[C@H]2N1
Standard InChI: InChI=1S/C14H17N3O3/c18-10-7-12-16-14(20)15-11(13(19)17(12)8-10)6-9-4-2-1-3-5-9/h1-5,10-12,18H,6-8H2,(H2,15,16,20)/t10-,11+,12+/m1/s1
Standard InChI Key: SBNFYKMBQKLKNE-WOPDTQHZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 275.31 | Molecular Weight (Monoisotopic): 275.1270 | AlogP: -0.17 | #Rotatable Bonds: 2 |
Polar Surface Area: 81.67 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.12 | CX Basic pKa: | CX LogP: 0.05 | CX LogD: 0.05 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.70 | Np Likeness Score: 0.47 |
1. Muller P, Lena G, Boilard E, Bezzine S, Lambeau G, Guichard G, Rognan D.. (2006) In silico-guided target identification of a scaffold-focused library: 1,3,5-triazepan-2,6-diones as novel phospholipase A2 inhibitors., 49 (23): [PMID:17154507] [10.1021/jm0606589] |
Source(1):